Fisher & Paykel Healthcare has reported a record first-half revenue of $951.2 million for the 2025 financial year, an 18% increase from the same period last year.
The company's net profit after tax for the first half was $153.2m, up 43%.
The strong results were attributed to new product introductions, changing clinical practices, and a relatively high hospital census.
The hospital product group had a 21% increase in revenue, while the homecare product group had a 14% increase.
The company's gross margin was 61.9%.
Fisher & Paykel Healthcare confirmed its full-year guidance for operating revenue and net profit after tax.
An interim dividend of 18.5 cents per ordinary share was approved by the company's directors.
See more
